Literature DB >> 1677687

Early postnatal testicular maldevelopment in cryptorchidism.

D S Huff1, F Hadziselimović, H M Snyder, B Blyth, J W Duckett.   

Abstract

It has been previously postulated that many cases of cryptorchidism are manifestations of a forme fruste of hypogonadotropic hypogonadism. In support of this theory the earliest postnatal histological abnormality in cryptorchid testes demonstrated by this morphometric study of semithin microscopic sections of testicular biopsies was hypoplasia of the Leydig cells, which was obvious from the first month of life. The second abnormality, defective transformation of gonocytes into adult dark spermatogonia, was significant from early in life. No reduction in the mean number of germ cells was detected in the first 7 months of life. The abnormal persistence of the untransformed gonocytes resulted in a total germ cell count that was similar to normal controls until the seventh month, when secondary degeneration of untransformed gonocytes led to a decrease in the total germ cell count. These findings are compatible with the hypothesis that the blunted neonatal surge of gonadotropins previously demonstrated in cryptorchid boys triggers a cascade of hormonal and secondary histological abnormalities that may culminate in a reduced fertility potential in adults. Early replacement hormonal therapy deserves further investigation as a rational approach to the treatment of germ cell maldevelopment and reduced fertility potential associated with cryptorchidism.

Entities:  

Mesh:

Year:  1991        PMID: 1677687     DOI: 10.1016/s0022-5347(17)37874-6

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  18 in total

1.  Endocrinological parameters in experimental unilateral undescended testis.

Authors:  M Srinivas; S Agarwala; P Jha; M M Misro; D K Mitra
Journal:  Indian J Pediatr       Date:  1999 Mar-Apr       Impact factor: 1.967

Review 2.  Germ cell development in the descended and cryptorchid testis and the effects of hormonal manipulation.

Authors:  C Ong; S Hasthorpe; J M Hutson
Journal:  Pediatr Surg Int       Date:  2005-02-23       Impact factor: 1.827

3.  Incidence at birth and natural history of cryptorchidism: a study of 10,730 consecutive male infants.

Authors:  P Ghirri; C Ciulli; M Vuerich; A Cuttano; M Faraoni; L Guerrini; C Spinelli; S Tognetti; A Boldrini
Journal:  J Endocrinol Invest       Date:  2002-09       Impact factor: 4.256

4.  Delayed treatment of undescended testes may promote hypogonadism and infertility.

Authors:  Julia Rohayem; Alessandra Luberto; Eberhard Nieschlag; Michael Zitzmann; Sabine Kliesch
Journal:  Endocrine       Date:  2017-01-09       Impact factor: 3.633

Review 5.  Opening remarks: cryptorchidism.

Authors:  F Hinman
Journal:  Eur J Pediatr       Date:  1993       Impact factor: 3.183

6.  Effects of laparoscopic division of spermatic vessels on histological changes of testes: long-term observation in the model of prepubertal rat.

Authors:  Daxing Tang; Karin Gorgas; Zacharias Zachariou
Journal:  Pediatr Surg Int       Date:  2007-11-06       Impact factor: 1.827

7.  Testicular and paratesticular pathology in infants and children: the histopathological experience of a tertiary paediatric unit over a 17 year period.

Authors:  F L Murphy; H Law; I Mushtaq; N J Sebire
Journal:  Pediatr Surg Int       Date:  2007-09       Impact factor: 1.827

8.  Combined therapy with LHRH and HCG in cryptorchid infants.

Authors:  R Lala; P Matarazzo; P Chiabotto; C de Sanctis; F Canavese; F Hadziselimovic
Journal:  Eur J Pediatr       Date:  1993       Impact factor: 3.183

Review 9.  Orchidopexy and its impact on fertility.

Authors:  Feilim Murphy; Thambipillai Sri Paran; Prem Puri
Journal:  Pediatr Surg Int       Date:  2007-03-13       Impact factor: 2.003

10.  Germ cell development in the postnatal testis: the key to prevent malignancy in cryptorchidism?

Authors:  John M Hutson; Ruili Li; Bridget R Southwell; Bodil L Petersen; Jorgen Thorup; Dina Cortes
Journal:  Front Endocrinol (Lausanne)       Date:  2013-01-03       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.